MyHep DVIR™ (28 tabs) is a a fixed dose combination quality assured generic of Sovaldi® (Sofosbuvir 40 mg) + Daklinza® (Daclatasvir 60 mg) produced in an FDA approved factory in India. It’s an antiviral prescription medication for the treatment of chronic Hepatitis C. It’s also used off-label for the treatment of Coronavirus (COVID-19).
- MyHep DVIR™ side effects profile is very mild especially with enough water intake
- Consult a doctor before concurrent administration of other drugs and supplements
- There are no foods to be avoided while taking MyHep DVIR™ except Grapefruit juice
Active Ingredients : Sofosbuvir 400 mg + Daclatasvir 60 mg
Produced by Mylan Pharmaceuticals® of the United States (US FDA approved manufacturer)